Day: December 17, 2021

The U.S. Centers for Disease Control and Prevention on Friday issued guidelines for keeping children in school even if they are unvaccinated or partially vaccinated and have been exposed to someone with COVID-19.

During a virtual briefing by the White House COVID-19 response team, CDC Director Rochelle Walensky said the test-to-stay protocol involves testing twice in a seven-day period anyone who has had close contact with someone infected with COVID-19. She said if exposed children meet certain criteria and continue to test negative, they can stay in school instead of quarantining at home.

Walensky said numerous jurisdictions have been experimenting with test-to-stay strategies. Some were testing every day, some every other day, and some twice a week. From those experiments, she said, the CDC will recommend no less than twice-weekly testing to adequately adhere to test-to-stay protocols.

The CDC also published studies conducted in the United States and internationally that looked at how COVID-19 is spread in schools, which helped form the basis for test-to-stay recommendations.

Walensky reported at least 39 U.S. states have more than 75 confirmed cases involving the omicron variant. She said the delta variant continues to circulate widely and remains the dominant strain in the United States, but omicron is spreading rapidly and is expected to become the dominant strain in the coming weeks.

The CDC director said omicron has been found among those who are vaccinated and boosted, and health officials believe these cases are milder or asymptomatic because of vaccine protection. “What we do know is we have the tools to protect ourselves against COVID-19,” she said.

White House Coronavirus Response Coordinator Jeff Zients said the U.S. is fully prepared to confront the variant, with ample supplies of vaccines and boosters.

“This is not a moment to panic, because we know how to protect people,” Zients said. “And we have the tools to do it.”

Some information for this report came from The Associated Press and Reuters,
…

Japanese Prime Minister Fumio Kishida said Friday his government is seeking to accelerate its COVID-19 booster shots campaign and has reached out to the head of U.S. pharmaceutical company Pfizer to secure additional vaccines.

Kishida told reporters the government has been negotiating to receive 120 million doses of Pfizer’s COVID-19 vaccine ahead of schedule. He said during his call with the company’s CEO, Albert Bourla, he also agreed to purchase two million doses of Pfizer’s oral COVID-19 treatment, Paxlovid.

The government started arrangements Thursday to adjust the timeframe for workers and patients in elder-care facilities to receive booster shots to six months after their second shots. Health officials shortened the original eight-month timeline between initial vaccinations and booster shots after the discovery of the new omicron variant of coronavirus, the virus that causes COVID-19.

Japan has confirmed a handful of omicron variant cases. The Tokyo Metropolitan Government confirmed on Friday that a man in his 20s who attended a soccer match near the capital was found positive for omicron.

Japanese Chief Cabinet Secretary Hirokazu Matsuno also confirmed 70 coronavirus cases have been found at the U.S. Camp Hansen military base in the southern island prefecture of Okinawa.

Matsuno said the Japanese government has urged U.S. officials there to thoroughly quarantine infected persons, identify close contacts at an early stage, and strengthen measures to prevent the spread of infection.

Some information for this report was provided by The Associated Press and Reuters.
…

After internal Facebook documents were shared widely with news organizations, the question remains whether and how Facebook will change. Michelle Quinn reports.
…

China and Russia have begun collaborating on technology to rival the United States’ GPS and European Galileo satellite navigation systems, as the two countries pursue closer military and strategic ties.

Earlier this year, China agreed to host ground monitoring stations for Russia’s GLONASS positioning system on its soil, which improves global range and accuracy but can pose a security risk. In turn, Russia agreed to host ground stations for China’s BeiDou system.

The reciprocal agreement indicates a growing level of trust and cooperation between Moscow and Beijing, says analyst Alexander Gabuev, senior fellow and chair of the Russia in the Asia-Pacific Program at the Carnegie Moscow Center.

“Russia’s schism with the West and deepening confrontation and competition between China and the U.S. as two superpowers is definitely contributing to rapprochement between Moscow and Beijing. There is a natural economic complementarity where Russia has (an) abundance of natural resources, and China has capital and technology to develop those resources. And finally, both are authoritarian states, so they don’t have this allergy when talking domestic political setup, or the poisoning of (Russian opposition leader) Alexi Navalny, or issues like Hong Kong or human rights in Xinjiang,” Gabuev told VOA.

It will take some time for the collaboration on satellite navigation systems to be felt on the ground.

“So far, we have yet to see important results, because in Russia, Russia still relies increasingly on GLONASS but also on GPS. We don’t have major BeiDou-linked projects,” Gabuev added.

Satellites

Satellites are seen as a crucial component of 21st century military power. Last month, Russia tested a missile against one of its own satellites. The U.S. said the resulting debris threatened astronauts on the International Space Station.

“What’s most troubling about that is the danger that it creates for the international community. It undermines strategic stability,” U.S. Secretary of Defense Lloyd Austin told reporters Nov. 17.

Russia, China and the U.S. are among several nations developing hypersonic missiles, which travel through the upper atmosphere at up to five times the speed of sound.

Space treaty

Russian Foreign Minister Sergei Lavrov said the U.S. had failed to engage on a joint Russian-Chinese space treaty.

“They have ignored for many years the initiative of Russia and China to prepare a treaty to prevent an arms race in space. They simply ignore it, insisting instead on developing some sort of universal rules,” Lavrov said.

In an interview June 11 with U.S. broadcaster NBC, Russian President Vladimir Putin said cooperation with Beijing was deepening.

“We have been working and will continue to work with China, which applies to all kinds of programs, including exploring deep space. And I think there is nothing but positive information here. Frankly, I don’t see any contradictions here,” Putin said.

There are limits to Russian and Chinese cooperation, Gabuev said.

“Both Russia and China are religious about their strategic autonomy. There is deep-seated nationalism, there is some level of mistrust and some level of competition in many of those areas where there is seeming complementarity, like space programs. I think that these advances in military technology is happening mostly in parallel, but not jointly.”

India

Gabuev notes that Russia has worked more closely with India than China, including on the development of the joint BrahMos cruise missile system since the 1990s.

“Russia felt secure enough to develop BrahMos missiles together with Indian colleagues. So, this military cooperation between Russia and China is deepening, it’s definitely causing a significant challenge to the West, particularly because it helps the PLA (China’s People’s Liberation Army) to become a really 21st century fighting power and a global military power. But at the same time, we don’t see the depth that exists between, for example, the U.S. and America’s allies,” Gabuev said.

India has also purchased Russia’s S-400 missile defense system, an attempt to counter China’s military might that also risks angering Delhi’s ally, the United States, and an indication of the complexity of strategic relations in a changing world order. 

 
…

The U.S. government on Thursday permanently eased some restrictions on a pill used to terminate early pregnancies, allowing the drug to be sent by mail rather than requiring it to be dispensed in person.

The decision by the Food and Drug Administration comes as the right to obtain an abortion, established in the 1973 Supreme Court ruling Roe v. Wade hangs in the balance.

The medication, generically known as mifepristone, is approved for use up to 10 weeks of pregnancy and is also sometimes prescribed to treat women who are having miscarriages.

“The FDA’s decision will come as a tremendous relief for countless abortion and miscarriage patients,” said Georgeanne Usova, senior legislative counsel at the American Civil Liberties Union.

The restrictions on the pill had been in place since the FDA approved the drug in 2000 and were lifted temporarily by the government earlier this year because of the pandemic. That enabled women to consult health care providers by telemedicine and receive the pills by mail. The FDA’s decision makes that temporary change permanent.

As a result of the FDA rule change, many patients will not need to go to a clinic, medical office or hospital in person to receive the medication but can opt to receive the pill through the mail from a certified prescriber or pharmacy.

The decision will increase access to medication abortion for women in remote and rural areas without providers nearby.

Low-income women who face obstacles reaching clinics such as lack of transportation and inability to take time off work will also gain greater access to the drug.

However, 19 states including Texas have laws that supersede the FDA decision by barring telehealth consultations or the mailing of abortion pills. Women in those states would not be able to make use of the rule change at home but could potentially travel to other states to obtain medication abortion.

States such as California and New York that have sought to strengthen access to abortion may make the drug available to women from other states.

The change is likely to add to the intense U.S. political debate over abortion. Conservative Supreme Court justices indicated in December 1 oral arguments over an abortion ban in Mississippi at 15 weeks of pregnancy that they were open to either gutting Roe or overturning it entirely. A decision is due by the end of June.

The Charlotte Lozier Institute and Susan B. Anthony List, which advocate against abortion, said in a statement that the FDA decision ignored data on complications and put women at risk.

The groups called on the FDA to restore the in-person dispensing requirement and add restrictions.

FDA records show that of the 3.7 million women who took Mifeprex, the branded version of the drug, to terminate a pregnancy between September 2000 and December 2018, 24 died from complications.

Some restrictions remain

The FDA left in place some restrictions, such as the need to use a certified pharmacy and requiring the prescribers to be certified. The ACLU said it was “disappointing that the FDA fell short of repealing all of its medically unnecessary restrictions on mifepristone, and these remaining obstacles should also be lifted.”

The organization sued the U.S. government on behalf of a Hawaii doctor and several professional health care associations in 2017, challenging the restrictions that it said limited access to medication abortion.

Medication abortion involves two drugs, taken over a day or two. The first, mifepristone, blocks the pregnancy-sustaining hormone progesterone. The second, misoprostol, induces uterine contractions.
…